FDA OKs Letermovir to Prevent CMV in Kidney Transplants ...Middle East

Letermovir was shown to be just as effective as valganciclovir in preventing CMV in kidney transplant recipients in new study published in JAMA; results prompt additional FDA approval for this indication. Medscape Medical News

Hence then, the article about fda oks letermovir to prevent cmv in kidney transplants was published today ( Wednesday 07/06/2023 - 06:36 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA OKs Letermovir to Prevent CMV in Kidney Transplants )

Also on site :

• Bank of England must plan for a financial crisis triggered by Aliens, says former policy expert
• Former UK police officer stripped of citizenship after moving to Russia
• Russia to launch rival to Elon Musk’s Starlink – space chief